Submission Details
| 510(k) Number | K190294 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 11, 2019 |
| Decision Date | March 15, 2019 |
| Days to Decision | 32 days |
| Submission Type | Special |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K190294 is an FDA 510(k) clearance for the CELL-DYN Emerald 22 AL System, a Counter, Differential Cell (Class II — Special Controls, product code GKZ), submitted by Abbott Laboratories (Santa Clara, US). The FDA issued a Cleared decision on March 15, 2019, 32 days after receiving the submission on February 11, 2019. This device falls under the Hematology review panel. Regulated under 21 CFR 864.5220.
| 510(k) Number | K190294 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 11, 2019 |
| Decision Date | March 15, 2019 |
| Days to Decision | 32 days |
| Submission Type | Special |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | GKZ — Counter, Differential Cell |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.5220 |